NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270:83-90.
Kessler A, Sollie S, Challacombe B, Briggs K, Van Hemelrijck M. The global prevalence of erectile dysfunction: a review. BJU Int. 2019;124:587–99. https://doi.org/10.1111/bju.14813.
Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schröder FH, Essink-Bot M-L. Erectile dysfunction and mental health in a general population of older men. J Sex Med. 2009;6:505–12. https://doi.org/10.1111/j.1743-6109.2008.01111.x.
Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Stefanadis C. The triad: erectile dysfunction–endothelial dysfunction–cardiovascular disease. Curr Pharm Des. 2008;14:3700–14.
Article CAS PubMed Google Scholar
Banks E, Joshy G, Abhayaratna WP, Kritharides L, Macdonald PS, Korda RJ, et al. Erectile dysfunction severity as a risk marker for cardiovascular disease hospitalisation and all-cause mortality: a prospective cohort study. PLoS Med. 2013;10:e1001372. https://doi.org/10.1371/journal.pmed.1001372.
Article PubMed PubMed Central Google Scholar
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet (Lond, Engl). 2020;395:795–808. https://doi.org/10.1016/S0140-6736(19)32008-2.
Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N. Engl J Med. 2023;389:1273–85. https://doi.org/10.1056/NEJMoa2206916.
Article CAS PubMed PubMed Central Google Scholar
Miner M, Parish SJ, Billups KL, Paulos M, Sigman M, Blaha MJ. Erectile dysfunction and subclinical cardiovascular disease. Sex Med Rev. 2019;7:455–63. https://doi.org/10.1016/j.sxmr.2018.01.001.
Feldman DI, Cainzos-Achirica M, Billups KL, DeFilippis AP, Chitaley K, Greenland P, et al. Subclinical vascular disease and subsequent erectile dysfunction: the multiethnic study of atherosclerosis (MESA). Clin Cardiol. 2016;39:291–8. https://doi.org/10.1002/clc.22530.
Article PubMed PubMed Central Google Scholar
Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50:285–94. https://doi.org/10.1016/j.arcmed.2019.08.009.
Article CAS PubMed Google Scholar
Kim SH, Cho YK, Kim Y-J, Jung CH, Lee WJ, Park J-Y, et al. Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study. Cardiovasc Diabetol. 2022;21:81. https://doi.org/10.1186/s12933-022-01522-8.
Article CAS PubMed PubMed Central Google Scholar
Zhu Y, Chen M, Liu K, Gao A, Kong X, Liu Y, et al. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors. J Atheroscler Thromb. 2022;29:1226–35. https://doi.org/10.5551/jat.63136.
Article CAS PubMed Google Scholar
Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical Considerations, and Uses to Inform Public Policy. Adv Nutr. 2016;7:121–34. https://doi.org/10.3945/an.115.009258.
Article PubMed PubMed Central Google Scholar
Derby CA, Araujo AB, Johannes CB, Feldman HA, McKinlay JB. Measurement of erectile dysfunction in population-based studies: the use of a single question self-assessment in the Massachusetts Male Aging Study. Int J Impot Res. 2000;12:197–204. https://doi.org/10.1038/sj.ijir.3900542.
Article CAS PubMed Google Scholar
Onat A, Can G, Kaya H, Hergenç G. Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipido. 2010;4:89–98. https://doi.org/10.1016/j.jacl.2010.02.005.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495–9. https://doi.org/10.1016/j.ijsu.2014.07.013.
Guo L, Nan Y, Yao L Association between atherogenic indexes and erectile dysfunction: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001-2004. International Urology and Nephrology. 2024. https://doi.org/10.1007/s11255-024-04050-4.
Montorsi P, Ravagnani PM, Galli S, Salonia A, Briganti A, Werba JP, et al. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol. 2006;50:721–31.
Jackson G, Boon N, Eardley I, Kirby M, Dean J, Hackett G, et al. Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus. Int J Clin Pract. 2010;64:848–57. https://doi.org/10.1111/j.1742-1241.2010.02410.x.
Article CAS PubMed Google Scholar
Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet (Lond, Engl). 2023;401:1293–301. https://doi.org/10.1016/S0140-6736(23)00215-5.
Kalelioglu T, Genc A, Karamustafalioglu N, Emul M. Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment. Diab Metab Syndr. 2017;11:S473–S5. https://doi.org/10.1016/j.dsx.2017.03.038.
Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010;10:248–52.
CAS PubMed PubMed Central Google Scholar
Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL). Clin Biochem. 2001;34:583–8.
Uslu AU, Kucuk A, Icli A, Cure E, Sakiz D, Arslan S, et al. Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus. Eurasia J Med. 2017;49:193–7. https://doi.org/10.5152/eurasianjmed.2017.17143.
Ermis E, Ozbay Ozyilmaz S, Salabas E, Senol C, Cengiz M, Allahverdiyev S, et al. The relationship between erectile dysfunction and the Atherogenic Index of Plasma. Int J Impot Res. 2020;32:462–8. https://doi.org/10.1038/s41443-019-0167-2.
Dilixiati D, Waili A, Tuerxunmaimaiti A, Tao L, Zebibula A, Rexiati M. Risk factors for erectile dysfunction in diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol. 2024;15:1368079. https://doi.org/10.3389/fendo.2024.1368079.
Sivaratnam L, Selimin DS, Abd Ghani SR, Nawi HM, Nawi AM. Behavior-related erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2021;18:121–43. https://doi.org/10.1016/j.jsxm.2020.09.009.
Kupelian V, Link CL, Rosen RC, McKinlay JB. Socioeconomic status, not race/ethnicity, contributes to variation in the prevalence of erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. J Sex Med. 2008;5:1325–33. https://doi.org/10.1111/j.1743-6109.2008.00822.x.
Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291:2978–84.
Article CAS PubMed Google Scholar
Cao S, Gan Y, Dong X, Liu J, Lu Z. Association of quantity and duration of smoking with erectile dysfunction: a dose-response meta-analysis. J Sex Med. 2014;11:2376–84. https://doi.org/10.1111/jsm.12641.
Wang L, Chen F, Xiaoqi C, Yujun C, Zijie L. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score. Angiology. 2021;72:181–6. https://doi.org/10.1177/0003319720949804.
Article CAS PubMed Google Scholar
Kim SC. Hyperlipidemia and erectile dysfunction. Asian J Androl. 2000;2:161–6.
留言 (0)